FATTY LIVER DISEASE, NONALCOHOLIC
Clinical trials for FATTY LIVER DISEASE, NONALCOHOLIC explained in plain language.
Never miss a new study
Get alerted when new FATTY LIVER DISEASE, NONALCOHOLIC trials appear
Sign up with your email to follow new studies for FATTY LIVER DISEASE, NONALCOHOLIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old heart drug could be new hope against fatty liver
Disease control Recruiting nowThis study tests whether a low dose of digoxin, a drug normally used for heart problems, can help people with a severe type of fatty liver disease called NASH (also known as MASH). The trial will involve 144 adults with biopsy-confirmed NASH and liver scarring. Participants will …
Matched conditions: FATTY LIVER DISEASE, NONALCOHOLIC
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Gut bacteria boost may fight fatty liver
Disease control Recruiting nowThis study tests whether a daily probiotic capsule can reduce liver fat and stiffness in adults with moderate fatty liver disease (MASLD). Sixty participants will take either the probiotic or a placebo for 6 months, with liver scans and blood tests at the start, 3 months, and 6 m…
Matched conditions: FATTY LIVER DISEASE, NONALCOHOLIC
Phase: PHASE2 • Sponsor: AB Biotics, SA • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New ultrasound device could replace MRI for liver fat measurement
Diagnosis Recruiting nowThis pilot study is testing a new Thermoacoustic Enhanced Ultrasound device to measure fat in the liver. Researchers will compare the device's readings to the gold-standard MRI measurement in 49 adults with fatty liver disease. The goal is to develop a more accessible and afforda…
Matched conditions: FATTY LIVER DISEASE, NONALCOHOLIC
Sponsor: Endra Lifesciences • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC